Creative Medical Technology Holdings Announces Positive Data and Patent Filing Using ImmCelz® to Treat Type 1 Diabetes

Author's Avatar
Jan 19, 2021
Article's Main Image

Possibility of Concurrent Immunological Protection with Beta Cell Regeneration Disclosed in Filed Patent Application

PR Newswire